SLC16A3 and arthritic joint disease: We next correlated SLC16A1 and SLC16A3 synovial mRNA expression with histological and clinical parameters using a publicly available dataset of a cohort of adult, naïve to treatment RA patients (http://www.peac-mrc.mds.qmul.ac.uk/index.php) (27) with an arthritis duration <12 months.